ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 349 filers reported holding ENCOMPASS HEALTH CORP in Q3 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,665 | -35.3% | 101 | -37.7% | 0.01% | -37.5% |
| Q1 2024 | $13,402 | +4.6% | 162 | -15.6% | 0.01% | 0.0% |
| Q4 2023 | $12,810 | -87.6% | 192 | -87.5% | 0.01% | -83.3% |
| Q3 2023 | $103,292 | +23.2% | 1,538 | +24.2% | 0.05% | 0.0% |
| Q2 2023 | $83,825 | +14.7% | 1,238 | -8.4% | 0.05% | +20.0% |
| Q1 2023 | $73,089 | -21.0% | 1,351 | -12.7% | 0.04% | -23.1% |
| Q4 2022 | $92,526 | +208.4% | 1,547 | +128.8% | 0.05% | +173.7% |
| Q3 2022 | $30,000 | -99.9% | 676 | -33.7% | 0.02% | -45.7% |
| Q2 2022 | $57,115,000 | +184141.9% | 1,019 | +137.5% | 0.04% | +40.0% |
| Q1 2022 | $31,000 | -8.8% | 429 | -18.0% | 0.02% | +13.6% |
| Q4 2021 | $34,000 | -2.9% | 523 | +11.5% | 0.02% | +10.0% |
| Q3 2021 | $35,000 | -5.4% | 469 | +6.3% | 0.02% | -33.3% |
| Q2 2021 | $37,000 | – | 441 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DARUMA CAPITAL MANAGEMENT LLC | 587,603 | $45,804,000 | 4.32% |
| Kalos Management, Inc. | 77,043 | $6,000,000 | 3.22% |
| MARIETTA INVESTMENT PARTNERS LLC | 101,122 | $7,882,000 | 2.34% |
| Copeland Capital Management, LLC | 471,462 | $36,750,000 | 2.22% |
| REINHART PARTNERS, LLC. | 278,916 | $21,742,000 | 1.97% |
| Rock Springs Capital Management LP | 676,500 | $52,733,000 | 1.91% |
| Wolf Group Capital Advisors | 35,599 | $2,775,000 | 1.81% |
| GARRISON BRADFORD & ASSOCIATES INC | 27,608 | $2,152,000 | 1.73% |
| BROADVIEW ADVISORS LLC | 123,907 | $9,659,000 | 1.65% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 70,000 | $5,457,000 | 1.64% |